{"id":569717,"date":"2026-07-27T01:53:11","date_gmt":"2026-07-27T01:53:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/569717\/"},"modified":"2026-07-27T01:53:11","modified_gmt":"2026-07-27T01:53:11","slug":"press-release-atea-pharmaceuticals-initiates-first-in-human-phase-1-clinical-trial-of-at-587-for-the-treatment-of-hepatitis-e-virus","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/569717\/","title":{"rendered":"[Press release] Atea Pharmaceuticals initiates first-in-human Phase 1 clinical trial of AT-587 for the treatment of hepatitis E virus"},"content":{"rendered":"<p>Atea Pharmaceuticals press release<\/p>\n<p>Atea Pharmaceuticals, Inc. announced the initiation of a first-in-human Phase 1 clinical trial evaluating AT-587, for the treatment of hepatitis E virus (HEV) infection.<\/p>\n<p>AT-587 is a proprietary oral antiviral nucleotide analog being developed for the treatment of HEV, a potentially serious liver disease that can lead to chronic infection, cirrhosis and liver failure in certain patient populations.<\/p>\n<p>The Phase 1 trial is a randomized, double-blind, placebo-controlled, sequential dose-escalation study designed to evaluate the safety, tolerability and pharmacokinetics of AT-587 in healthy volunteers. The study includes both single ascending dose and multiple ascending dose components, as well as an embedded food-effect assessment.<\/p>\n<p>Read the full press release <a href=\"https:\/\/ir.ateapharma.com\/news-releases\/news-release-details\/atea-pharmaceuticals-initiates-first-human-phase-1-clinical\" target=\"_blank\" rel=\"noopener nofollow\">here<\/a>.<\/p>\n<p>\u00a0<\/p>\n<p>Source : <a href=\"https:\/\/ir.ateapharma.com\/news-releases\/news-release-details\/atea-pharmaceuticals-initiates-first-human-phase-1-clinical\" target=\"_blank\" rel=\"nofollow noopener\">Atea Pharmaceuticals, Inc.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Atea Pharmaceuticals press release Atea Pharmaceuticals, Inc. announced the initiation of a first-in-human Phase 1 clinical trial evaluating&hellip;\n","protected":false},"author":2,"featured_media":102477,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-569717","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/569717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=569717"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/569717\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/102477"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=569717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=569717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=569717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}